BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 29156792)

  • 21. Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing.
    Medina Diaz I; Nocon A; Mehnert DH; Fredebohm J; Diehl F; Holtrup F
    PLoS One; 2016; 11(11):e0166354. PubMed ID: 27832189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients.
    Lavacchi D; Gelmini S; Calabri A; Rossi G; Simi L; Caliman E; Mancini I; Salvianti F; Petroni G; Guidolin A; Scolari F; Messerini L; Pillozzi S; Pinzani P; Antonuzzo L
    Heliyon; 2023 Nov; 9(11):e21853. PubMed ID: 38027900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ampholytic ion-exchange magnetic beads: a promising tool for selecting short fragments in circulating cell-free DNA analysis.
    He G; Wang W; Zhou Y; Zhao G; Liao J
    Front Oncol; 2024; 14():1397680. PubMed ID: 38779084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased detection of circulating tumor DNA by short fragment enrichment.
    Liu Y; Liu Y; Wang Y; Li L; Yao W; Song Y; Liu B; Chen W; Santarpia M; Rossi E; Zamarchi R; Wang Z; Wang Q; Cheng G
    Transl Lung Cancer Res; 2021 Mar; 10(3):1501-1511. PubMed ID: 33889525
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Wang ZY; Ding XQ; Zhu H; Wang RX; Pan XR; Tong JH
    Front Oncol; 2019; 9():1295. PubMed ID: 31850201
    [No Abstract]   [Full Text] [Related]  

  • 26. Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma.
    Abramson DH; Mandelker D; Francis JH; Dunkel IJ; Brannon AR; Benayed R; Berger MF; Arcila ME; Ladanyi M; Friedman DN; Jayakumaran G; Diosdado MS; Robbins MA; Haggag-Lindgren D; Shukla N; Walsh M; Kothari P; Tsui DWY
    Ophthalmol Sci; 2021 Mar; 1(1):100015. PubMed ID: 36246006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of circulating cell-free DNA recovery for KRAS mutation and HPV detection in plasma.
    Mazurek AM; Fiszer-Kierzkowska A; Rutkowski T; Składowski K; Pierzyna M; Scieglińska D; Woźniak G; Głowacki G; Kawczyński R; Małusecka E
    Cancer Biomark; 2013; 13(5):385-94. PubMed ID: 24440979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of the first external quality assessment scheme (EQA) for isolation and analysis of circulating tumour DNA (ctDNA).
    Haselmann V; Ahmad-Nejad P; Geilenkeuser WJ; Duda A; Gabor M; Eichner R; Patton S; Neumaier M
    Clin Chem Lab Med; 2018 Jan; 56(2):220-228. PubMed ID: 28841569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis.
    He Y; Ma X; Chen K; Liu F; Cai S; Han-Zhang H; Hou T; Xiang J; Peng J
    Cancer Manag Res; 2020; 12():1621-1630. PubMed ID: 32184665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol.
    Sorber L; Zwaenepoel K; Jacobs J; De Winne K; Goethals S; Reclusa P; Van Casteren K; Augustus E; Lardon F; Roeyen G; Peeters M; Van Meerbeeck J; Rolfo C; Pauwels P
    Cancers (Basel); 2019 Mar; 11(4):. PubMed ID: 30935089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Origin of circulating free DNA in patients with lung cancer.
    Abe T; Nakashima C; Sato A; Harada Y; Sueoka E; Kimura S; Kawaguchi A; Sueoka-Aragane N
    PLoS One; 2020; 15(7):e0235611. PubMed ID: 32634139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review.
    Schraa SJ; van Rooijen KL; Koopman M; Vink GR; Fijneman RJA
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carrier molecules and extraction of circulating tumor DNA for next generation sequencing in colorectal cancer.
    Beránek M; Sirák I; Vošmik M; Petera J; Drastíková M; Palička V
    Acta Medica (Hradec Kralove); 2016; 59(2):54-8. PubMed ID: 27526306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-free circulating tumor DNA in colorectal cancer: a proof of concept with simplified methodology.
    Bosque J; Guirao C; Ferrández A; Suarez N; Castillejo MI; Anguita D; Pamies M; Moya A; Soto JL; Gallego Plazas J
    Clin Transl Oncol; 2022 Oct; 24(10):1924-1931. PubMed ID: 35499600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Preanalytical and Analytical Methods on Cell-Free DNA Diagnostics.
    Krasic J; Abramovic I; Vrtaric A; Nikolac Gabaj N; Kralik-Oguic S; Katusic Bojanac A; Jezek D; Sincic N
    Front Cell Dev Biol; 2021; 9():686149. PubMed ID: 34552921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing.
    Demuth C; Spindler KG; Johansen JS; Pallisgaard N; Nielsen D; Hogdall E; Vittrup B; Sorensen BS
    Transl Oncol; 2018 Oct; 11(5):1220-1224. PubMed ID: 30086420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.
    Kim ST; Lee WS; Lanman RB; Mortimer S; Zill OA; Kim KM; Jang KT; Kim SH; Park SH; Park JO; Park YS; Lim HY; Eltoukhy H; Kang WK; Lee WY; Kim HC; Park K; Lee J; Talasaz A
    Oncotarget; 2015 Nov; 6(37):40360-9. PubMed ID: 26452027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management.
    Hallermayr A; Steinke-Lange V; Vogelsang H; Rentsch M; de Wit M; Haberl C; Holinski-Feder E; Pickl JMA
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Specific Gravity-Free Method for the Isolation of Circulating Tumor KRAS Mutant DNA and Exosome in Colorectal Cancer.
    Lee TH; Park E; Goh YG; Lee HB; Rou WS; Eun HS
    Micromachines (Basel); 2021 Aug; 12(8):. PubMed ID: 34442609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparinase enables reliable quantification of circulating tumor DNA from heparinized plasma samples by droplet digital PCR.
    Sefrioui D; Beaussire L; Clatot F; Delacour J; Perdrix A; Frebourg T; Michel P; Di Fiore F; Sarafan-Vasseur N
    Clin Chim Acta; 2017 Sep; 472():75-79. PubMed ID: 28729136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.